TABLE 1

Participant characteristics

n9
Age (years)47 ± 2.8
Sex (male/female)7/2
BMI33.5 ± 2.1
HbA1c (%)10.3 ± 0.6
Weight P+ (kg)*96.5 ± 4.8
Weight P− (kg)95.8 ± 4.7
Waist-to-hip ratio1.0 ± 0.01
Medication2 I, 1 M, 5 M + S, 1 M + I
  • Data are means ± SE unless otherwise indicated. I, insulin alone; M, metformin alone; M + S, metformin plus sufonylurea; I + M, metformin plus insulin;

  • *

    * Weight after 21 days of pioglitazone (P+) administration;

  • weight after 21 days of placebo (P−) administration.